← Browse by Condition
Medical Condition

wound dehiscence

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 3

ClinicalMetric tracks all active clinical trials for wound dehiscence sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — wound dehiscence Clinical Trials

How many clinical trials are currently recruiting for wound dehiscence?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for wound dehiscence, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for wound dehiscence?
wound dehiscence research spans Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a wound dehiscence clinical trial?
Eligibility criteria for wound dehiscence trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
1
Top Sponsors
Uppsala University 1 trial
Benjamín Gonzalo Rodríguez Méndez 1 trial
Major Extremity Trauma Research Consortium 1 trial

Recruiting Clinical Trials

NCT07003906
Recruiting
Treating Emergency Laparotomy Incisions With Negative Pressure Wound Therapy
Enrollment
720 pts
Location
Sweden
Sponsor
Uppsala University
View Trial →
NCT07541196
Recruiting
PAW-Hydrogel for Chronic Wound Healing
Enrollment
50 pts
Location
Mexico
Sponsor
Benjamín Gonzalo Rodríguez Mén...
View Trial →
NCT06337292 Phase 3
Recruiting
Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures
Enrollment
352 pts
Location
United States
Sponsor
Major Extremity Trauma Researc...
View Trial →

Related Conditions

surgical incision (1) surgical site infection (1) incisional hernia (1) quality of life (1) diabetic foot ulcer dfu (1) pressure ulcer pu (1) venous leg ulcer (1) arterial ulcer (1) chronic wound (1) fracture of tibia (1) wound heal (1) infected wound (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology